NASDAQ:BCRX Archives - BioPharmaJournal

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) Enrols the first Patient in Study...

Kate Hudson - March 4, 2022 0

BioCryst Pharmaceutical Inc. (NASDAQ: BCRX) Commences Enrolment in REDEEM-2 Study Evaluating...

Kate Hudson - December 7, 2021 0

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) Presents Safety and Efficacy Data From...

Kate Hudson - November 19, 2021 0

The Ministry of Health and Prevention (MOHAP) in the UAE Approves...

Matt Wade - September 21, 2021 0

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) Demonstrates Improvement In Hemoglobin Using BCX9930 In...

Gavins Felicity - April 28, 2021 0

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Commences ORLADEYO Shipment to US Patients for...

Ward Sport - December 24, 2020 0

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Receives FDA Approval For ORLADEYO™ In Preventing...

Ward Sport - December 7, 2020 0

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Announces Important Upcoming Milestones

Kate Hudson - November 12, 2020 0

BioCryst Pharmaceutical Inc. (NASDAQ:BCRX) Announced Data For BCX9930 Clinical Trial In...

Gavins Felicity - October 13, 2020 0

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Says the US Government is Purchasing an...

Ward Sport - September 8, 2020 0

12 Page 1 of 2

Marker Therapeutics Inc. (NASDAQ: MRKR) Receives FD Approval For MT-601 IND...

Gavins Felicity - August 15, 2022 0

Marker Therapeutics Inc. (NASDAQ: MRKR) has announced that the US FD has approved its Investigational New Drug application for MT -601 for treatment of...

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces PALISADE-1 Phase 3 Study Findings...

August 12, 2022

ObsEva SA (NASDA: OBSV) Announce Corporate Restructuring And Resignation of Chief...

August 11, 2022

Why Crypto Stocks May be the Best Route to Monetizing the...

August 10, 2022

Evofem Bioscience Inc. (NASDAQ: EVFM) Commends US Multi-Agencies For Clarifying Birth...

August 10, 2022

Tag: NASDAQ:BCRX

Recent Post